ABSTRACT
The aim of this study is to investigate the efficacy of levetiracetam, a new antiepileptic drug, as add-on treatment in children with intractable epilepsy.
This retrospective study was performed in 53 children (aged 1-17.4 years, mean: 7.9 years) with intractable epilepsy were followed up for 16.8 months (1 month-4.3 years). The duration and frequency of seizures were documanted with standard interval.
At the end of the follow-up period, 26 patients (49.1%) were seizure free, the seizure frequency was markedly (>50%) decreased in 11 patients (20.8%). On the other hand, seizure frequency did not change in 11 patients (20.8%) and in 4 patients (7.5%) the seizure frequency increased. Levetiracetam was found to be efficant in 69.9% (37/53) of patients (seizure free or reduction >50% in seizure frequency). Thirtytwo percent of the patients had adverse effects and there was no statistically significant relationship between side effects and the dosage of drugs.
Levetiracetam proved to be effective and well tolerable drug in children with refractory epilepsy.
Keywords: Child, intractable epilepsy, levetiracetam